Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...

Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can cause dangerously high cholesterol and early heart disease ...

FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to reduce plasma LDL-C levels.

PHOENIX — Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can cause dangerously high cholesterol and early ...

Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...

LOUISVILLE, Ky., July 27, 2022 – The Family Heart Foundation, a leading research and advocacy organization, completed an analysis of its large U.S. Family Heart Database TM showing that while the ...

A new review found that a genetic condition that puts people at a risk for high cholesterol is not protective against type 2 diabetes (T2D), despite previous studies suggesting the opposite. Data from ...

Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.